Fowlicidin, Myeloid antimicrobial peptide 27

General Information


DRACP ID  DRACP03878

Peptide Name   Fowlicidin, Myeloid antimicrobial peptide 27

Sequence  RFGRFLRKIRRFRPKVTITIQGSARFG

Sequence Length  27

UniProt ID  Q2IAL7 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C149H247N51O32

Absent amino acids  CDEHMNWY

Common amino acids  R

Mass  372883

Pl  13.28

Basic residues  9

Acidic residues  0

Hydrophobic residues  10

Net charge  9

Boman Index  -8935

Hydrophobicity  -49.26

Aliphatic Index  72.22

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25818457

Title  Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of ?-helix-based peptide amphiphiles

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13910

DRACP is developed by Dr.Zheng's team.